Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1925 1
1962 1
1966 2
1967 1
1969 2
1970 1
1976 2
1978 1
1980 6
1981 2
1982 3
1983 6
1984 3
1986 3
1987 1
1988 2
1989 3
1990 3
1991 3
1992 6
1993 5
1994 3
1995 3
1996 9
1997 12
1998 8
1999 19
2000 26
2001 28
2002 42
2003 51
2004 65
2005 82
2006 101
2007 112
2008 114
2009 130
2010 143
2011 182
2012 239
2013 265
2014 274
2015 318
2016 332
2017 363
2018 409
2019 475
2020 562
2021 657
2022 738
2023 761
2024 874
2025 858
2026 8

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

7,428 results

Results by year

Filters applied: . Clear all
Page 1
Cardiolipin-mimic lipid nanoparticles without antibody modification delivered senolytic in vivo CAR-T therapy for inflamm-aging.
Zhang Z, Ma B, Li B, Li Z, Gao M, Zhao H, Peng R, Hu J, Wang Y, You W, Gui X, Wang R, Hu X, Chen B, Zhang Y, Hao Y, Sun X, Rao P, Zhang L, Lu M, Zhou D, Yang Y, Deng M, Miao L. Zhang Z, et al. Among authors: ma b. Cell Rep Med. 2025 Jul 15;6(7):102209. doi: 10.1016/j.xcrm.2025.102209. Epub 2025 Jul 1. Cell Rep Med. 2025. PMID: 40602406 Free PMC article.
A pan-KRAS inhibitor and its derived degrader elicit multifaceted anti-tumor efficacy in KRAS-driven cancers.
Feng J, Xiao X, Xia X, Min J, Tang W, Shi X, Xu K, Zhou G, Li K, Shen P, Bao R, Wu S, Lin M, Yuan K, Lian Z, Hu L, Li N, Wu Z, Zhai X, Liu X, Hu K, Wu J, Ding C, Zhao H, Gong X, Zhang S, Jin J, Li D, Liu M, Ye Y, Ma B, Guo RT, Zhang A, Pang X. Feng J, et al. Among authors: ma b. Cancer Cell. 2025 Oct 13;43(10):1866-1884.e12. doi: 10.1016/j.ccell.2025.07.006. Epub 2025 Aug 7. Cancer Cell. 2025. PMID: 40780213 Free article.
Evolving landscape of nasopharyngeal carcinoma therapy.
Chin KW, Chong WQ, Goh BC, Ma BBY. Chin KW, et al. Among authors: ma bby. Nat Cancer. 2025 Sep;6(9):1480-1482. doi: 10.1038/s43018-025-01045-7. Nat Cancer. 2025. PMID: 40973778 No abstract available.
Bioactivation and reactivity research advances-2024 year in review.
Liu J, Argikar UA, Brunetti P, Chatzopoulou M, Chen L, Cho S, Hauri S, Kramlinger V, Lang J, Ma B, Rehm K, Seneviratne HK, Tang LWT, Tran JC, Zhong G, Khojasteh SC. Liu J, et al. Among authors: ma b. Drug Metab Rev. 2025 Nov;57(4):362-399. doi: 10.1080/03602532.2025.2530407. Epub 2025 Jul 28. Drug Metab Rev. 2025. PMID: 40642940 Review.
7,428 results